Tuesday 25 September 2018
Contact US    |    Archive
reuters
1 months ago

Long-acting injection a shot in the arm for GSK s HIV business

A long-acting injection developed by GlaxoSmithKline and given once a month has proved as effective as standard daily pills for controlling the AIDS virus, lifting prospects for the British drugmaker s key HIV business.

Read on the original site


هذه الصفحة هي مجرد قاریء تلقائي للأخبار باستخدام خدمة الـ RSS و بأن نشر هذه الأخبار هنا لاتعني تأییدها علی الإطلاق.
Hashtags:   

Long

 | 

acting

 | 

injection

 | 

shot

 | 

the

 | 

arm

 | 

for

 | 

GSK

 | 

HIV

 | 

business

 | 
Most Popular (6 hours)

Most Popular (24 hours)

Most Popular (a week)